Conserving surgery in inflammatory breast cancer after neoadjuvant chemotherapy in patients with clinical complete response: the ConSIBreC randomized controlled trial

Front Oncol. 2024 Feb 22:14:1372633. doi: 10.3389/fonc.2024.1372633. eCollection 2024.
No abstract available

Keywords: ConSIBreC trial; breast conserving surgery; inflammatory breast cancer; neoadjuvant chemotherapy; radical mastectomy.

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.